Smith & Nephew Executives Reinvest 2025 Final Dividend Into ADS Purchases
Claim 55% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
Smith & Nephew Snats ( (SNN) ) has issued an announcement.
On 3 June 2026, Smith & Nephew disclosed that its chief executive and several senior managers acquired American Depositary Shares through the company’s Employee Stock Purchase Plan. The purchases, executed on the New York Stock Exchange at about $29.83 per ADS, followed the reinvestment of the 2025 final dividend paid on 27 May 2026 and highlight ongoing equity participation by top leadership in line with UK market abuse disclosure rules.
The transactions involved CEO Deepak Nath and three other senior executives, with each dealing reported as a single transaction under the firm’s Dividend Re-Investment Plan. While routine in nature, the move underscores continued alignment of management incentives with shareholder interests, as Smith & Nephew maintains transparency obligations as a foreign private issuer under U.S. securities regulation and the UK Market Abuse Regulation.
The most recent analyst rating on (SNN) stock is a Hold
with a $30.00 price target.
To see the full list of analyst forecasts on Smith & Nephew Snats stock,
see the SNN Stock Forecast page.
Spark’s Take on SNN Stock
According to Spark, TipRanks’ AI Analyst, SNN is a Outperform.
The score is driven primarily by improving financial performance (margin and cash flow rebound) and supportive technicals (price above major moving averages with positive momentum). Valuation is only average at a 22.7 P/E, while the earnings call adds confidence via upbeat 2026 growth/profit guidance but flags meaningful near-term tariff and reimbursement headwinds.
To see Spark’s full report on SNN stock,
click here.
More about Smith & Nephew Snats
Smith & Nephew plc is a global medical technology company headquartered in Watford, England, best known for its orthopaedics, sports medicine and advanced wound management products. The group focuses on surgical and care solutions that serve hospitals and healthcare providers worldwide, with its shares traded in London and American Depositary Shares listed on the New York Stock Exchange.
Average Trading Volume: 1,054,752
Technical Sentiment Signal: Hold
Current Market Cap: $12.45B
Find detailed analytics on SNN stock on TipRanks’ Stock Analysis page.
